Edmonton psychiatry professor aims to treat mental illness with psychedelics through new company
An interview with Dr. Peter Silverstone about the beginnings of Zylorion and its projections for the coming years.
< back
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.